Study the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

Completed · Phase 2

Conditions studied: Infectious Skin Disease, Bacterial Skin Disease

In brief

A Phase II trial to demonstrate the safety and efficacy of PTK 0796 in the treatment of complicated skin and skin structure infections (cSSSI).

Key facts

Study ID

NCT03716024

Run by

Paratek Pharmaceuticals Inc

People needed

234

Starts

2007-07-18

Expected to finish

2008-01-07

Last updated by the study team

2020-10-12

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients, ages 18 years to 80 years
• Has an acute complicated skin and skin structure infection
• Female patients must not be pregnant at the time of enrollment and must agree to a reliable method of birth control during the study and for 30 days following the last dose of study drug

You may not qualify if…

• Has received an investigational drug within past 1 month
• Has been previously enrolled in this protocol
• Has received >48 hr of a potentially effective systemic antibiotic immediately prior to study drug
• Is nursing

Where it is running

• Paratek Recruiting Site — Anaheim, California, United States
• Paratek Recruiting Site — Buena Park, California, United States
• Paratek Recruiting Site — Chula Vista, California, United States
• Paratek Recruiting Site — Hawaiian Gardens, California, United States
• Paratek Recruiting Site — Oceanside, California, United States
• Paratek Recruiting Site — San Jose, California, United States
• Paratek Recruiting Site — Indianapolis, Indiana, United States
• Paratek Recruiting Site — Butte, Montana, United States
• Paratek Recruiting Site — Electra, Texas, United States
• Paratek Recruiting Site — Houston, Texas, United States
• Paratek Recruiting Site — Wichita Falls, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.